Exosomal circCCAR1 released by HCC cells enhanced resistance to anti-PD-1 immunotherapy and reduced the survival time of HCC-bearing mice by retarding CD8+ T cell expansion and infiltration into tumor tissues. This evidence concerns the gene CD8A and hepatocellular carcinoma.